Jodi Hecht, PhD, joined Dana-Farber Innovations in 2017. She negotiates industry non-clinical research agreements and evaluates and commercializes intellectual property arising from Dana-Farber research. She serves as the primary alliance manager for Dana-Farber and Novartis Drug Discovery and Translational Research Program.
Prior to joining Dana-Farber Innovations, Dr. Hecht worked as a Licensing Associate in the Technology Ventures office at Beth Israel Deaconess Medical Center. Dr. Hecht received a PhD in Molecular Biology from Boston University, and an MSc in Biology and Vision Science and a BSc in Biochemistry, both from the University of Waterloo.